Sort
51,593 grants matching “hepatitis”
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
$871,109Thomas E Lane · University Of California-Irvine · R35 · FY2025 · NS
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis
$871,014Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2015 · DK
Regulation of Liver by Nuclear Ca2+ Signaling
$870,938Yale University · P01 · FY2005 · DK
The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation
$870,427Tracey Simon · Brigham And Women'S Hospital · R01 · FY2024 · HL
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$870,391James L. Sorensen · University Of California, San Francisco · UG1 · FY2015 · DA
The Role of Inflammation and Stroma in Digestive Cancer
$870,263Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2007 · CA
Immune Control and Evasion during Acute HCV Infection
$869,999Massachusetts General Hospital · U19 · FY2005 · AI
HIV and musculoskeletal frailty: implications for care, policy and research
$869,878Elena Losina · Brigham And Women'S Hospital · R01 · FY2024 · NR
Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV
$869,817Suneil Krishna Koliwad · University Of California, San Francisco · R01 · FY2020 · DK
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$869,573Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2025 · AI
Clinical-Res-Project1
$869,292Susan A Berry · Children'S Research Institute · U54 · FY2019 · HD
Multidisciplinary Studies of Hematopoietic Malignancies
$868,892Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Disordered Cellular Cholesterol Movement, Cell Death, and Multisystem Disease
$868,830Stephen Dean Turley · Ut Southwestern Medical Center · R01 · FY2012 · HL
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$868,634University Of Louisiana At Lafayette · U42 · FY2003 · RR
Biofilm Epidemiology and Mechanisms in Colon Cancer
$868,377Cynthia L Sears · Johns Hopkins University · R01 · FY2017 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$868,304University Of Pittsburgh At Pittsburgh · U01 · FY2000 · AI
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$868,300University Of Texas Sw Med Ctr/Dallas · U01 · FY2000 · AI
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$868,039Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2022 · GM
EARLY HEPATIC DISSEMINATION OF PANCREATIC CANCER: EFFECTIVE TREATMENT BY SYSTEMIC CHEMOTHERAPY-ENHANCED ALPHA-PARTICLE RADIOTHERAPY
$867,712The Johns Hopkins University · · FY2024 · Defense Health Agency
Metabolic Studies of Mouse Models of Obesity and Diabetes
$867,659Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2025 · DK
Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes
$867,274Fasiha Kanwal · Baylor College Of Medicine · R01 · FY2025 · CA
Drosophila models of human mitochondrial diseases
$867,258Norbert Perrimon · Harvard Medical School · R24 · FY2023 · OD
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam
$867,212Don C Des Jarlais · New York University · R01 · FY2020 · DA
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$867,166Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2025 · AI
Natural History of Hepatitis C Infection in HIV Disease
$867,151Deborah Cotton · Boston University Medical Campus · R01 · FY2007 · DA